Cristcot
PrivateLast Round
Series B
Oct 23, 2019
Total Funding Raised
$13.73M
Company Overview
Cristcot is a healthcare company that develops a disposable suppository applicator designed for the hygienic administration of rectal medications to treat various conditions such as constipation, gastrointestinal diseases, and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cristcot Comps
Public and private peers based on sector, stage, and business model.
Cristcot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 23, 2019 |
Key People
Founding team and executive leadership
Cristcot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shepherd Kaplan Krochuk | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Preparing for commercial launch of novel ulcerative colitis treatment.
- Aug 11, 2025
First product, a therapy for ulcerative colitis, is in Phase 3 trials.
Cristcot Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cristcot's valuation, stock price, and market status.